Nuclear magnetic resonance structure revealed that the human polyomavirus JC virus agnoprotein contains an α-helix encompassing the Leu/Ile/Phe-rich domain

Journal of Virology

Volumn 88, Issue 12, 2014, Pages 6556-6575

  Coric, Pascale ^b   Saribas, A Sami ^a   Abou Gharbia, Magid ^c   Childers, Wayne ^c   White, Martyn K ^a   Bouaziz, Serge ^b   Safak, Mahmut ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGNOPROTEIN; ISOLEUCINE; LEUCINE; PHENYLALANINE;

ALPHA HELIX; AMINO ACID SUBSTITUTION; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; DIMERIZATION; DNA REPLICATION; HYDROPHOBICITY; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE MICROSCOPY; JC VIRUS; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURE ACTIVITY RELATION; VIRUS MORPHOLOGY; VIRUS REPLICATION; VIRUS TRANSCRIPTION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; CELL LINE; DIMERIZATION; HUMANS; JC VIRUS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; POLYOMAVIRUS INFECTIONS; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS REPLICATION;

EID: 84901341422     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00146-14     Document Type: Article

References (79)

1. Sami Saribas A, Abou-Gharbia M, Childers W, Sariyer IK, White MK, Safak M. 2013. Essential roles of Leu/Ile/Phe-rich domain of JC virus agnoprotein in dimer/oligomer formation, protein stability and splicing of viral transcripts. Virology 443:161-176. http://dx.doi.org/10.1016/j.virol.2013.05.003.
2. Ellis LC, Norton E, Dang X, Koralnik IJ. 2013. Agnogene deletion in a novel pathogenic JC virus isolate impairs VP1 expression and virion production. PLoS One 8:e80840. http://dx.doi.org/10.1371/journal.pone.0080840.
3. De Gascun CF, Carr MJ. 2013. Human polyomavirus reactivation: disease pathogenesis and treatment approaches. Clin. Dev. Immunol. 2013: 373579. http://dx.doi.org/10.1155/2013/373579.
4. Saribas AS, White MK, Safak M. 2012. JC virus agnoprotein enhances large T antigen binding to the origin of viralDNAreplication: evidence for its involvement in viral DNA replication. Virology 433:12-26. http://dx.doi.org/10.1016/j.virol.2012.06.017.
5. Unterstab G, Gosert R, Leuenberger D, Lorentz P, Rinaldo CH, Hirsch HH. 2010. The polyomavirus BK agnoprotein co-localizes with lipid droplets. Virology 399:322-331. http://dx.doi.org/10.1016/j.virol.2010.01.011.
6. Roy A, Kucukural A, Zhang Y. 2010. I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 5:725-738. http://dx.doi.org/10.1038/nprot.2010.5.
7. Saribas AS, Arachea BT, White MK, Viola RE, Safak M. 2011. Human polyomavirus JC small regulatory agnoprotein forms highly stable dimers and oligomers: implications for their roles in agnoprotein function. Virology 420:51-65. http://dx.doi.org/10.1016/j.virol.2011.08.015.
8. Dyson HJ, Wright PE. 2005. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6:197-208. http://dx.doi.org/10.1038/nrm1589.
9. Fink AL. 2005. Natively unfolded proteins. Curr. Opin. Struct. Biol. 15: 35-41. http://dx.doi.org/10.1016/j.sbi.2005.01.002.
10. Ou HD, Kwiatkowski W, Deerinck TJ, Noske A, Blain KY, Land HS, Soria C, Powers CJ, May AP, Shu X, Tsien RY, Fitzpatrick JA, Long JA, Ellisman MH, Choe S, O'Shea CC. 2012. A structural basis for the assembly and functions of a viral polymer that inactivates multiple tumor suppressors. Cell 151:304-319. http://dx.doi.org/10.1016/j.cell.2012.08.035.
11. Safak M, Sadowska B, Barrucco R, Khalili K. 2002. Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J. Virol. 76:3828-3838. http://dx.doi.org/10.1128/JVI.76.8.3828-3838.2002.
12. Darbinyan A, Darbinian N, Safak M, Radhakrishnan S, Giordano A, Khalili K. 2002. Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein. Oncogene 21:5574-5581. http://dx.doi.org/10.1038/sj.onc.1205744.
13. Okada Y, Suzuki T, Sunden Y, Orba Y, Kose S, Imamoto N, Takahashi H, Tanaka S, Hall WW, Nagashima K, Sawa H. 2005. Dissociation of heterochromatin protein 1 from lamin B receptor induced by human polyomavirus agnoprotein: role in nuclear egress of viral particles. EMBO Rep. 6:452-457. http://dx.doi.org/10.1038/sj.embor.7400406.
14. Suzuki T, Orba Y, Makino Y, Okada Y, Sunden Y, Hasegawa H, Hall WW, Sawa H. 2013. Viroporin activity of the JC polyomavirus is regulated by interactions with the adaptor protein complex 3. Proc. Natl. Acad. Sci. U. S. A. 110:18668-18673. http://dx.doi.org/10.1073/pnas.1311457110.
15. Sariyer IK, Khalili K, Safak M. 2008. Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: inhibition by small t antigen. Virology 375:464-479. http://dx.doi.org/10.1016/j.virol.2008.02.020.
16. Safak M, Khalili K. 2001. Physical and functional interaction between viral and cellular proteins modulate JCV gene transcription. J. Neurovirol. 7:288-292. http://dx.doi.org/10.1080/13550280152537111.
17. Safak M, Barrucco R, Darbinyan A, Okada Y, Nagashima K, Khalili K. 2001. Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J. Virol. 75: 1476-1486. http://dx.doi.org/10.1128/JVI.75.3.1476-1486.2001.
18. Suzuki T, Orba Y, Okada Y, Sunden Y, Kimura T, Tanaka S, Nagashima K, Hall WW, Sawa H. 2010. The human polyoma JC virus agnoprotein acts as a viroporin. PLoS Pathog. 6:e1000801. http://dx.doi.org/10.1371/journal.ppat.1000801.
19. Sariyer IK, Akan I, Palermo V, Gordon J, Khalili K, Safak M. 2006. Phosphorylation mutants of JC virus agnoprotein are unable to sustain the viral infection cycle. J. Virol. 80:3893-3903. http://dx.doi.org/10.1128/JVI.80.8.3893-3903.2006.
20. Johannessen M, Walquist M, Gerits N, Dragset M, Spang A, Moens U. 2011. BKV agnoprotein interacts with alpha-soluble N-ethylmaleimidesensitive fusion attachment protein, and negatively influences transport of VSVG-EGFP. PLoS One 6:e24489. http://dx.doi.org/10.1371/journal.pone.0024489.
21. Merabova N, Kaminski R, Krynska B, Amini S, Khalili K, Darbinyan A. 2012. JCV agnoprotein-induced reduction in CXCL5/LIX secretion by oligodendrocytes is associated with activation of apoptotic signaling in neurons. J. Cell. Physiol. 227:3119-3127. http://dx.doi.org/10.1002/jcp.23065.
22. Merabova N, Kaniowska D, Kaminski R, Deshmane SL, White MK, Amini S, Darbinyan A, Khalili K. 2008. JC virus agnoprotein inhibits in vitro differentiation of oligodendrocytes and promotes apoptosis. J. Virol. 82:1558-1569. http://dx.doi.org/10.1128/JVI.01680-07.
23. Myhre MR, Olsen GH, Gosert R, Hirsch HH, Rinaldo CH. 2010. Clinical polyomavirus BK variants with agnogene deletion are nonfunctional but rescued by trans-complementation. Virology 398:12-20. http://dx.doi.org/10.1016/j.virol.2009.11.029.
24. Sariyer IK, Saribas AS, White MK, Safak M. 2011. Infection by agnoprotein- negative mutants of polyomavirus JC and SV40 results in the release of virions that are mostly deficient in DNA content. Virol. J. 8:255. http://dx.doi.org/10.1186/1743-422X-8-255.
25. Major EO. 2010. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu. Rev. Med. 61:35-47. http://dx.doi.org/10.1146/annurev.med.080708.082655.
26. Berger JR, Concha M. 1995. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J. Neurovirol. 1:5-18. http://dx.doi.org/10.3109/13550289509111006.
27. Berger JR. 2011. The basis for modeling progressive multifocal leukoencephalopathy pathogenesis. Curr. Opin. Neurol. 24:262-267. http://dx.doi.org/10.1097/WCO.0b013e328346d2a3.
28. Major EO, Amemiya K, Tornatore CS, HouffSA, Berger JR. 1992. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin. Microbiol. Rev. 5:49-73.
29. Assetta B, Maginnis MS, Gracia Ahufinger I, Haley SA, Gee GV, Nelson CD, O'Hara BA, Allen Ramdial SA, Atwood WJ. 2013. 5-HT2 receptors facilitate JC polyomavirus entry. J. Virol. 87:13490-13498. http://dx.doi.org/10.1128/JVI.02252-13.
30. Neu U, Maginnis MS, Palma AS, Stroh LJ, Nelson CD, Feizi T, Atwood WJ, Stehle T. 2010. Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif. Cell Host Microbe 8:309-319. http://dx.doi.org/10.1016/j.chom.2010.09.004.
31. Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. 2005. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med. 353:375-381. http://dx.doi.org/10.1056/NEJMoa051847.
32. Kleinschmidt-DeMasters BK, Tyler KL. 2005. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N. Engl. J. Med. 353:369-374. http://dx.doi.org/10.1056/NEJMoa051782.
33. Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P. 2005. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N. Engl. J. Med. 353:362-368. http://dx.doi.org/10.1056/NEJMoa051586.
34. McGuffin LJ, Bryson K, Jones DT. 2000. The PSIPRED protein structure prediction server. Bioinformatics 16:404-405. http://dx.doi.org/10.1093/bioinformatics/16.4.404.
35. Cornille F, Wecker K, Loffet A, Genet Roques RB. 1999. Efficient solid-phase synthesis of Vpr from HIV-1 using low quantities of uniformly 13C-, 15N-labeled amino acids for NMR structural studies. J. Pept. Res. 54:427-435. http://dx.doi.org/10.1034/j.1399-3011.1999.00129.x.
36. Piotto M, Saudek V, Sklenar V. 1992. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2:661-665. http://dx.doi.org/10.1007/BF02192855.
37. Hwang TL, Shaka AJ. 1995. Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson. A 112:275-279.
38. Jeener J, Meier BH, Bachmann P, Ernst RR. 1979. Investigation of exchange processes by two-dimensional NMR spectroscopy. J. Chem. Phys. 71:5246-5253. http://dx.doi.org/10.1063/1.438333.
39. Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, Ulrich EL, Markley JL, Ionides J, Laue ED. 2005. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59: 687-696. http://dx.doi.org/10.1002/prot.20449.
40. Nilges M. 1995. Calculation of protein structures with ambiguous distance restraints. Automated assignment of ambiguous NOE crosspeaks and disulphide connectivities. J. Mol. Biol. 245:645-660.
41. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse- Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. 1998. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54:905-921. http://dx.doi.org/10.1107/S0907444998003254.
42. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM. 1996. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8:477-486.
43. DeLano W. 2002. The PyMOL molecular graphics system. DeLano Scientific, San Carlos, CA.
44. Bourbigot S, Beltz H, Denis J, Morellet N, Roques BP, Mely Y, Bouaziz S. 2005. The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipperlike domain. Biochem. J. 387:333-341. http://dx.doi.org/10.1042/BJ20041759.
45. Arkin IT, Sukharev SI, Blount P, Kung C, Brunger AT. 1998. Helicity, membrane incorporation, orientation and thermal stability of the large conductance mechanosensitive ion channel from E. coli. Biochim. Biophys. Acta 1369:131-140. http://dx.doi.org/10.1016/S0005-2736(97)00219-8.
46. Fleming KG, Hohl TM, Yu RC, Muller SA, Wolpensinger B, Engel A, Engelhardt H, Brunger AT, Sollner TH, Hanson PI. 1998. A revised model for the oligomeric state of the N-ethylmaleimide-sensitive fusion protein, NSF. J. Biol. Chem. 273:15675-15681. http://dx.doi.org/10.1074/jbc.273.25.15675.
47. Morellet N, Bouaziz S, Petitjean P, Roques BP. 2003. NMR structure of the HIV-1 regulatory protein VPR. J. Mol. Biol. 327:215-227. http://dx.doi.org/10.1016/S0022-2836(03)00060-3.
48. Doreleijers JF, Sousa da Silva AW, Krieger E, Nabuurs SB, Spronk CA, Stevens TJ, Vranken WF, Vriend G, Vuister GW. 2012. CING: an integrated residue-based structure validation program suite. J. Biomol. NMR 54:267-283. http://dx.doi.org/10.1007/s10858-012-9669-7.
49. Major EO, Miller AE, Mourrain P, Traub RG, de Widt E, Sever J. 1985. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc. Natl. Acad. Sci. U. S. A. 82:1257-1261. http://dx.doi.org/10.1073/pnas.82.4.1257.
50. Del Valle L, Gordon J, Enam S, Delbue S, Croul S, Abraham S, Radhakrishnan S, Assimakopoulou M, Katsetos CD, Khalili K. 2002. Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J. Natl. Cancer Inst. 94:267-273. http://dx.doi.org/10.1093/jnci/94.4.267.
51. Ziegler K, Bui T, Frisque RJ, Grandinetti A, Nerurkar VR. 2004. A rapid in vitro polyomavirus DNA replication assay. J. Virol. Methods 122:123-127. http://dx.doi.org/10.1016/j.jviromet.2004.08.012.
52. Combet C, Blanchet C, Geourjon C, Deleage G. 2000. NPS@: network protein sequence analysis. Trends Biochem. Sci. 25:147-150. http://dx.doi.org/10.1016/S0968-0004(99)01540-6.
53. Snider C, Jayasinghe S, Hristova K, White SH. 2009. MPEx: a tool for exploring membrane proteins. Protein Sci. 18:2624-2628. http://dx.doi.org/10.1002/pro.256.
54. 2O/trifluoroethanol. Comparison with the Vpr N-terminal (1-51) and C-terminal (52-96) domains. Eur. J. Biochem. 269:3779-3788. http://dx.doi.org/10.1046/j.1432-1033.2002.03067.x.
55. Rance M, Sorensen OW, Bodenhausen G, Wagner G, Ernst RR, Wuthrich K. 1983. Improved spectral resolution in COSY 1HNMRspectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 117:479-485. http://dx.doi.org/10.1016/0006-291X(83)91225-1.
56. Marion D, Wuthrich K. 1983. Application of phase sensitive twodimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. Biochem. Biophys. Res. Commun. 113:967-974. http://dx.doi.org/10.1016/0006-291X(83)91093-8.
57. Griesinger C, Otting G, Wuthrich K, Ernst RR. 1988. Clear TOCSY for 1H spin system identification in macromolecules. J. Am. Chem. Soc. 110: 7870-7872. http://dx.doi.org/10.1021/ja00231a044.
58. Kumar A, Ernst RR, Wuthrich K. 1980. A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem. Biophys. Res. Commun. 95:1-6. http://dx.doi.org/10.1016/0006-291X(80)90695-6.
59. Wuthrich K. 1986. NMR of proteins and nucleic acids. Wiley Interscience, Hoboken, NJ.
60. Brunger AT. 1992. A system for X-ray crystallography and NMR. Yale University Press, New Haven, CT.
61. Hirt B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369. http://dx.doi.org/10.1016/0022-2836(67)90307-5.
62. Dunker AK, Cortese MS, Romero P, Iakoucheva LM, Uversky VN. 2005. Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J. 272:5129-5148. http://dx.doi.org/10.1111/j.1742-4658.2005.04948.x.
63. Uversky VN, Oldfield CJ, Dunker AK. 2005. Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J. Mol. Recognit. 18:343-384. http://dx.doi.org/10.1002/jmr.747.
64. Sheehy AM, Gaddis NC, Choi JD, Malim MH. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650. http://dx.doi.org/10.1038/nature00939.
65. Gouttenoire J, Penin F, Moradpour D. 2010. Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory. Rev. Med. Virol. 20:117-129. http://dx.doi.org/10.1002/rmv.640.
66. Hoenen T, Biedenkopf N, Zielecki F, Jung S, Groseth A, Feldmann H, Becker S. 2010. Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription. J. Virol. 84: 7053-7063. http://dx.doi.org/10.1128/JVI.00737-10.
67. Cuesta I, Nunez-Ramirez R, Scheres SH, Gai D, Chen XS, Fanning E, Carazo JM. 2010. Conformational rearrangements of SV40 large T antigen during early replication events. J. Mol. Biol. 397:1276-1286. http://dx.doi.org/10.1016/j.jmb.2010.02.042.
68. Foster EC, Simmons DT. 2010. The SV40 large T-antigen origin binding domain directly participates in DNA unwinding. Biochemistry 49:2087-2096. http://dx.doi.org/10.1021/bi901827k.
69. Bernacchi S, Mercenne G, Tournaire C, Marquet R, Paillart JC. 2011. Importance of the proline-rich multimerization domain on the oligomerization and nucleic acid binding properties of HIV-1 Vif. Nucleic Acids Res. 39:2404-2415. http://dx.doi.org/10.1093/nar/gkq979.
70. Lu JX, Sharpe S, Ghirlando R, Yau WM, Tycko R. 2010. Oligomerization state and supramolecular structure of the HIV-1 Vpu protein transmembrane segment in phospholipid bilayers. Protein Sci. 19:1877-1896. http://dx.doi.org/10.1002/pro.474.
71. Daugherty MD, Booth DS, Jayaraman B, Cheng Y, Frankel AD. 2010. HIV Rev response element (RRE) directs assembly of the Rev homooligomer into discrete asymmetric complexes. Proc. Natl. Acad. Sci. U. S. A. 107:12481-12486. http://dx.doi.org/10.1073/pnas.1007022107.
72. Daugherty MD, Liu B, Frankel AD. 2010. Structural basis for cooperative RNA binding and export complex assembly by HIV Rev. Nat. Struct. Mol. Biol. 17:1337-1342. http://dx.doi.org/10.1038/nsmb.1902.
73. Cullen BR. 2003. Nuclear mRNA export: insights from virology. Trends Biochem. Sci. 28:419-424. http://dx.doi.org/10.1016/S0968-0004(03)00142-7.
74. Cullen BR. 2003. Nuclear RNA export. J. Cell Sci. 116:587-597. http://dx.doi.org/10.1242/jcs.00268.
75. Saribas SA, Mun S, Johnson J, El-Hajmoussa M, White MK, Safak S. 2014. Human polyoma JC virus minor capsid proteins, VP2 and VP3, enhance large T antigen binding to the origin of viral DNA replication: evidence for their involvement in regulation of the viral DNA replication. Virology 449:1-16. http://dx.doi.org/10.1016/j.virol.2013.10.031.
76. Yatherajam G, Huang W, Flint SJ. 2011. Export of adenoviral late mRNA from the nucleus requires the Nxf1/Tap export receptor. J. Virol. 85: 1429-1438. http://dx.doi.org/10.1128/JVI.02108-10.
77. Corpet F. 1988. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16:10881-10890. http://dx.doi.org/10.1093/nar/16.22.10881.
78. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680. http://dx.doi.org/10.1093/nar/22.22.4673.
79. Akan I, Sariyer IK, BiffiR, Palermo V, Woolridge S, White MK, Amini S, Khalili K, Safak M. 2006. Human polyomavirus JCV late leader peptide region contains important regulatory elements. Virology 349:66-78. http://dx.doi.org/10.1016/j.virol.2006.01.025.